| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.17 | 9e-07 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.18 | 9e-07 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.23 | 3e-06 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.22 | 5e-06 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.14 | 5e-06 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-06 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.14 | 6e-06 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.15 | 6e-06 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.17 | 7e-06 |